회사소개
사업소개
치료기술
특수방사선
면역치료
암종별치료
혈액암
폐암
위암(소화기계통)
간암
대장암
췌장암
전립선암
유방암
난소암 자궁암
기타희귀암(루프스)
최근소식
논문
치료사례
동영상게시판
사진게시판
고객센터
상담문의
자주묻는 질문
최근소식
최근소식
회사소개
사업소개
치료기술
암종별치료
최근소식
고객센터
논문
논문
치료사례
동영상게시판
사진게시판
논문
번호
제목
날짜
345
2025년 Molecular Therapy:Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation
2025년 Molecular Therapy:Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation
2025-02-10
344
2025년 Nature Immunology:A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
2025년 Nature Immunology:A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
2025-02-10
343
2025년 Molecular Therapy - Methods & Clinical Development:High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells
2025년 Molecular Therapy - Methods & Clinical Development:High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells
2025-02-10
342
2025년 Nature Medicine:Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
2025년 Nature Medicine:Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
2025-02-10
341
2025년 Nature Immunology:Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2025년 Nature Immunology:Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2025-02-10
340
2025년 Haematologica:Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed
2025년 Haematologica:Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed
2025-02-10
339
2025년 Nature Medicine:Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
2025년 Nature Medicine:Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
2025-02-10
338
2025년 Cell:YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
2025년 Cell:YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
2025-02-07
337
2025년 Science Advances:Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
2025년 Science Advances:Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
2025-02-07
336
2025년 Nature Communications:CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
2025년 Nature Communications:CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
2025-02-07
제목
내용
제목+내용
검색
처음
1
페이지
2
페이지
3
페이지
4
페이지
열린
5
페이지
6
페이지
7
페이지
8
페이지
9
페이지
10
페이지
다음
맨끝